Form Type: 4

SEC EDGAR Link
Accession Number:0001213900-20-022546
Date:2020-08-13
Issuer: CORMEDIX INC. (CRMD)
Original Submission Date:

Reporting Person:

BALUCH KHOSO
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000 BERKELEY HEIGHTS, NJ 07922

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-08-13 P 4,830 a $4.14 60,905 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY COMMON STOCK) 5.63 deemed execution date 0 ( ) 2030-02-25 common stock 100,630 $5.63 100,630 direct
STOCK OPTION (RIGHT TO BUY COMMON STOCK) 6.82 deemed execution date 0 ( ) 2029-09-26 common stock 120,000 $6.82 120,000 direct
STOCK OPTION (RIGHT TO BUY COMMON STOCK) 8.3 deemed execution date 0 ( ) 2029-01-10 common stock 69,600 $8.30 69,600 direct
STOCK OPTION (RIGHT TO BUY COMMON STOCK) 12.6 deemed execution date 0 ( ) 2026-09-30 common stock 250,000 $12.60 250,000 direct
STOCK OPTION (RIGHT TO BUY COMMON STOCK) 12.6 deemed execution date 0 ( ) 2026-09-30 common stock 60,000 $12.60 60,000 direct
Footnotes
IDfootnote
f1 this transaction was executed in multiple trades at prices ranging from $4.1297 to $4.14. the price reported in column 4 is a weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
f2 these options were granted on 02/25/2020. these options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
f3 the options will vest over four (4) years in four (4) equal annual installments on the first four (4) anniversaries of september 26, 2019, provided, in all cases, that executive remains an employee of, or a consultant to, the company through the applicable vesting date.
f4 these options were granted on 1/10/2019. these options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. these options include options to purchase 7,000 shares that are subject to vesting each on january 10, 2021 and january 10, 2022.
f5 these options were granted 9/30/2016. the option vests as follows: 25% on 10/3/2017, 25% on 10/3/2018, 25% on 10/3/2019, and 25% on 10/3/2020.
f6 these options were granted 9/30/2016. the option vests based on certain performance milestones. if such milestones are met prior to 12/31/18, then the option will not vest until 12/31/18. the option will be forfeited if such milestones are not met by 10/3/2020.
WhaleWisdom Logo

Elevate your investments